# Evaluation of Virtual Versus Traditional Study Conducted in a Group Pilot Study in Adult Patients With Type 1 Diabetes Mellitus (eStudy)

> **NCT03260868** · PHASE4 · TERMINATED · sponsor: **Sanofi** · enrollment: 15 (actual)

## Conditions studied

- Type 1 Diabetes Mellitus

## Interventions

- **DRUG:** Insulin glargine, 300 units per milliliter (U/mL)
- **DRUG:** Background therapy: Rapid Acting meal time insulin analogs (Humalog, Novolog or Apidra)

## Key facts

- **NCT ID:** NCT03260868
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-09-19
- **Primary completion:** 2018-11-22
- **Final completion:** 2018-11-22
- **Target enrollment:** 15 (ACTUAL)
- **Why stopped:** Due to "prolonged low participant recruitment"
- **Last updated:** 2022-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03260868

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03260868, "Evaluation of Virtual Versus Traditional Study Conducted in a Group Pilot Study in Adult Patients With Type 1 Diabetes Mellitus (eStudy)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03260868. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*